Translated title of the contribution: General profile of fluvoxamine

D. De Maio, A. Bertolino, M. Casacchia, G. Ceccarelli, U. Ecari, C. Giove, A. Marino, A. A. Rizzoli, F. Savoldi

Research output: Contribution to journalArticlepeer-review


A brief report on the Consensus Conference on Fluvoxamina held in Moasca (Asti) in September 1990 in presented which describes a general profile of the drug. Fluvoxamine (a Selective Serotonin Reuptake Inhibitor) main features are reported, which include its clinically proven efficacy as and antidepressant agent, with a particularly strong efficacy on suicidal thoughts, and a particularly favourable safety profile (i.e. virtual absence of anticholinergicc activity, lack of cardiotoxicity. The clinically proven efficacy of fluvoxamine in the treatment of Anxiety Disorders (Panic attacks and Obsessive-Compulsive Disorder) is also reported. Besides these already established therapeutic indications, fluvoxamine can play a useful role in the treatment of other disorders (Eating disorders, Aggressive Behaviour Drug Use Disorder, etc.) biochemically characterized by a disordered central serotoninergic neurotransmission.

Translated title of the contributionGeneral profile of fluvoxamine
Original languageItalian
Pages (from-to)626-650
Number of pages25
JournalRivista Sperimentale di Freniatria e Medicina Legale delle Alienazioni Mentali
Issue number4
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'General profile of fluvoxamine'. Together they form a unique fingerprint.

Cite this